Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial)

URN to cite this document:: urn:nbn:de:bvb:355-epub-547322
DOI to cite this document:: 10.5283/epub.54732

Breyer, Johannes ; Eckstein, Markus ; Sikic, Danijel ; Wezel, Felix ; Roghmann, Florian ; Brehmer, Mirco ; Wirtz, Ralph M. ; Jarczyk, Jonas ; Erben, Philipp ; Bahlinger, Veronika ; Goldschmidt, Franziska ; Fechner, Guido ; Chen, Jack ; Paxinos, Ellen ; Bates, Michael ; Haas, Maximilian ; Zengerling, Friedemann ; Bolenz, Christian ; Burger, Maximilian ; Hartmann, Arndt ; Kriegmair, Maximilian C. ; BRIDGE Consortium e.V., .

License: Creative Commons Attribution 4.0
PDF - Published Version
(1MB)

Date of publication of this fulltext: 21 Sep 2023 04:36

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

To determine whether Xpert bladder cancer monitor, a noninvasive PCR-based biomarker test, can predict the need for 2nd transurethral resection of the bladder (TURB) better than clinical assessment. Patients scheduled for TURB were prospectively screened. After initial TURB, patients were assigned to 2nd TURB or follow-up cystoscopy at 3 months (FU) by clinicians’ discretion. Central urine ...